Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
US ˙ NasdaqGM ˙ US86366E1064

SecurityGPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Citadel Advisors Llc ownership in GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 0 shares of Structure Therapeutics Inc. - Depositary Receipt (Common Stock) (US:GPCR) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 772,518 shares of Structure Therapeutics Inc. - Depositary Receipt (Common Stock). This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (GPCR) in the form of stock options. The firm currently holds call options representing 60,100 of underlying shares valued at $2,896,820 USD and put options representing 54,300 of underlying shares valued at $2,617,260 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 0 -772,518 -100.00 0 -100.00
2026-02-17 2025-12-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 772,518 328,718 74.07 53,729 332.38 0.0081
2025-11-14 2025-09-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 443,800 -884,679 -66.59 12,426 -54.90 0.0019
2025-08-14 2025-06-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 1,328,479 336,139 33.87 27,553 60.40 0.0048
2025-05-15 2025-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 992,340 -486,999 -32.92 17,177 -57.18 0.0033
2025-02-14 2024-12-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 1,479,339 27,841 1.92 40,120 -37.02 0.0069
2024-11-14 2024-09-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 1,451,498 43,113 3.06 63,706 15.19 0.0123
2024-08-14 2024-06-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 1,408,385 132,523 10.39 55,307 1.14 0.0112
2024-05-15 2024-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 1,275,862 122,877 10.66 54,683 16.36 0.0105
2024-02-14 2023-12-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 1,152,985 72,393 6.70 46,996 -13.74 0.0094
2023-11-14 2023-09-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 1,080,592 730,929 209.04 54,483 274.84 0.0117
2023-08-14 2023-06-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 349,663 -16,624 -4.54 14,535 66.82 0.0030
2023-05-15 2023-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS 86366E106 366,287 366,287 8,714 0.0019
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 60,100 -24.21 2,897 -47.49 n/a n/a n/a
2026-02-17 2025-12-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 79,300 -27.97 5,515 78.94 n/a n/a n/a
2025-11-14 2025-09-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 110,100 35.59 3,083 83.02 n/a n/a n/a
2025-08-14 2025-06-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 81,200 81.66 1,684 117.85 n/a n/a n/a
2025-05-15 2025-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 44,700 59.64 774 1.84 n/a n/a n/a
2025-02-14 2024-12-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 28,000 -38.33 759 -61.90 n/a n/a n/a
2024-11-14 2024-09-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 45,400 -33.24 1,993 -25.39 n/a n/a n/a
2024-08-14 2024-06-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 68,000 -26.65 2,670 -32.80 n/a n/a n/a
2024-05-15 2024-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 92,700 142.67 3,973 155.17 n/a n/a n/a
2024-02-14 2023-12-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Call 38,200 1,557 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 54,300 -0.91 2,617 -31.33 n/a n/a n/a
2026-02-17 2025-12-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 54,800 -34.29 3,811 63.21 n/a n/a n/a
2025-11-14 2025-09-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 83,400 -6.40 2,335 26.42 n/a n/a n/a
2025-08-14 2025-06-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 89,100 -24.04 1,848 -9.01 n/a n/a n/a
2025-05-15 2025-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 117,300 -20.85 2,030 -49.49 n/a n/a n/a
2025-02-14 2024-12-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 148,200 119.56 4,019 35.69 n/a n/a n/a
2024-11-14 2024-09-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 67,500 -27.73 2,963 -19.23 n/a n/a n/a
2024-08-14 2024-06-30 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 93,400 92.18 3,668 76.13 n/a n/a n/a
2024-05-15 2024-03-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 48,600 98.37 2,083 108.62 n/a n/a n/a
2024-02-14 2023-12-31 13F STRUCTURE THERAPEUTICS SPONSORED ADS Put 24,500 999 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.